Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Why is Pharma Betting So Big on Innovation in Boston?
|
Luke Timmerman |
10/27/09 |
Boston
|
|
Autism Gets a Boost: Seaside Therapeutics Raises $30M To Develop First Drugs That Might Work
|
Luke Timmerman |
09/17/09 |
Boston
|
|
Acceleron Aims for Anemia Cure, Mascoma to Pump Out Biofuels For Chevron, Genzyme Chief to Head Boston Fed, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
09/16/09 |
Boston
|
|
AstraZeneca Plans Local Job Cuts, Report Says
|
Ryan McBride |
09/11/09 |
Boston
|
|
Genocea, Attracting Merck and Wyeth Vaccine Gurus, Pushes New Immunizations to Clinic
|
Luke Timmerman |
08/26/09 |
Boston
|
|
Seattle Genetics Snags Milestone
|
Luke Timmerman |
08/10/09 |
Seattle
|
|
MSM Protein Technologies Scores Antibody-Drug Discovery Partnerships
|
Luke Timmerman |
07/30/09 |
Boston
|
|
Dr. Sue Skates Where the Puck is Heading in Life Sciences–Waltham
|
Luke Timmerman |
05/19/09 |
Boston
|
|
NKT Therapeutics Aims For Severe Asthma, Targeting Natural Killer T Cells
|
Ryan McBride |
05/18/09 |
Boston
|
|
Infinity Pharma Lead Cancer Drug Trial Halted, Ends in Failure
|
Ryan McBride |
04/15/09 |
Boston
|
|
Calixa Passes Key Safety Test in Clinical Trial of New Antibiotic
|
Luke Timmerman |
03/24/09 |
San Diego
|
|
Two Simple Ways to Revitalize Seattle Biotech
|
Stewart Lyman |
02/09/09 |
Seattle
|
|
Genzyme and Boston Scientific Get Good News From the FDA; Acusphere and Targanta Not So Much; TransMedics Pulls IPO Plug; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
12/17/08 |
Boston
|
|
Prostate Cancer Drug Vaults OncoGenex Onto Investor Radar Screens
|
Luke Timmerman |
12/16/08 |
Seattle
|
|
Santarus Nabs U.S. Rights for Two Drugs in Cosmo Collaboration
|
Ryan McBride |
12/15/08 |
San Diego
|
|
Infinity Pharmaceuticals Gets Back Full Rights to Cancer Drugs From AstraZeneca
|
Luke Timmerman |
12/11/08 |
Boston
|
|
SunEthanol Picks Up $25M, New Name; Infinity Pharma Pairs with Purdue Pharma; In-Q-Tel Taps Two Local Firms, & More Boston-Area Deals News
|
Rebecca Zacks |
11/24/08 |
Boston
|
|
Infinity Snags $75 Million Through Alliance with Purdue Pharma and Mundipharma
|
Luke Timmerman |
11/20/08 |
Boston
|
|
Santarus Takes on Marketing Goliaths With Faster-Acting Heartburn Drug
|
Luke Timmerman |
10/17/08 |
San Diego
|
|
BG Medicine, Targeting Clues in Blood, Aims to Predict Whether a Drug Will Help
|
Luke Timmerman |
07/29/08 |
Boston
|
|
Boston Scientific Wins Stent Approval, Resolvyx Moves Closer to Fish-Oil Drug Trials, Codon Cuts Algae Fuel Deal, & More Life Sciences News
|
Rebecca Zacks |
07/09/08 |
Boston
|
|
.406 Ventures Backs Open-Source Video Firm, Thermo Fisher Boosts RNAi Efforts, Cubist Bonds with AstraZeneca, & More Deals News
|
Rebecca Zacks |
07/07/08 |
Boston
|
|
Icahn Jabs Biogen Idec, Says Its Board Had `Very Little’ Input in Sale Process
|
Luke Timmerman |
06/05/08 |
Boston
|
|
Infinity Drug Slows Spread of Deadly Stomach Cancer—FDA Clears Accelerated Trial
|
Luke Timmerman |
05/31/08 |
Boston
|
|
Biogen Idec-Icahn Story Likely Far From Over; History Says the Activist Investor Will Act Again
|
Robert Buderi |
12/18/07 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
